Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
26.34 USD | -1.16% | +20.49% | +27.36% |
Financials (USD)
Sales 2024 * | 5.83M | Sales 2025 * | - | Capitalization | 469M |
---|---|---|---|---|---|
Net income 2024 * | -100M | Net income 2025 * | -73M | EV / Sales 2024 * | 34.6 x |
Net cash position 2024 * | 267M | Net cash position 2025 * | 377M | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-2.55
x | P/E ratio 2025 * |
-4.34
x | Employees | 38 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 39.27% |
Latest transcript on Cartesian Therapeutics, Inc.
1 day | -1.16% | ||
1 week | +20.49% | ||
Current month | +19.35% | ||
1 month | +40.33% | ||
3 months | +11.55% | ||
6 months | -16.38% | ||
Current year | +27.36% |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.02% | 0 M€ | 0.00% | - | |
0.01% | 0 M€ | 0.00% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-16 | 26.34 | -1.16% | 31,363 |
24-05-15 | 26.65 | +7.68% | 123,376 |
24-05-14 | 24.75 | +15.38% | 164,730 |
24-05-13 | 21.45 | +1.32% | 25,200 |
24-05-10 | 21.17 | -3.16% | 54,832 |
Delayed Quote Nasdaq, May 16, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+27.36% | 469M | |
+8.29% | 114B | |
+10.21% | 104B | |
+0.67% | 22.28B | |
-11.90% | 22.41B | |
-5.43% | 19.07B | |
-37.36% | 18B | |
-5.17% | 17.89B | |
+7.70% | 14.28B | |
+37.65% | 12.55B |
- Stock Market
- Equities
- RNAC Stock